Published in Orphanet J Rare Dis on May 03, 2013
Cervical lymph node diseases in children. GMS Curr Top Otorhinolaryngol Head Neck Surg (2014) 0.81
Gastrointestinal aspects of vasculitides. Nat Rev Gastroenterol Hepatol (2016) 0.76
Lupus Gastrointestinal Tract Vasculopathy: Lupus "Enteritis" Involving the Entire Gastrointestinal Tract from Esophagus to Rectum. Case Rep Gastroenterol (2017) 0.75
Systemic lupus erythematosus with intestinal perforation: A case report. Exp Ther Med (2015) 0.75
Atypical Presenting Symptoms of Acute Onset Systemic Lupus Erythematosus with Enteritis and Cystitis. Case Rep Med (2016) 0.75
[Recurrent lupus enteritis improved by Azathioprine]. Pan Afr Med J (2015) 0.75
Characteristics of azathioprine use and cessation in a longitudinal lupus cohort. Lupus Sci Med (2015) 0.75
Mesenteric vasculitis in children with systemic lupus erythematosus. Clin Rheumatol (2015) 0.75
Gastrointestinal system manifestations in juvenile systemic lupus erythematosus. Clin Rheumatol (2017) 0.75
The 1982 revised criteria for the classification of systemic lupus erythematosus. Arthritis Rheum (1982) 67.54
Updating the American College of Rheumatology revised criteria for the classification of systemic lupus erythematosus. Arthritis Rheum (1997) 43.47
International consensus statement on an update of the classification criteria for definite antiphospholipid syndrome (APS). J Thromb Haemost (2006) 16.11
Derivation of the SLEDAI. A disease activity index for lupus patients. The Committee on Prognosis Studies in SLE. Arthritis Rheum (1992) 14.73
BILAG 2004. Development and initial validation of an updated version of the British Isles Lupus Assessment Group's disease activity index for patients with systemic lupus erythematosus. Rheumatology (Oxford) (2005) 2.37
Acute abdominal pain in systemic lupus erythematosus: focus on lupus enteritis (gastrointestinal vasculitis). Ann Rheum Dis (2002) 1.83
A review of gastrointestinal manifestations of systemic lupus erythematosus. Rheumatology (Oxford) (1999) 1.60
CT features of systemic lupus erythematosus in patients with acute abdominal pain: emphasis on ischemic bowel disease. Radiology (1999) 1.58
Systemic lupus erythematosus simulating acute surgical condition of the abdomen. N Engl J Med (1958) 1.53
Acute mesenteric ischemia: diagnosis with contrast-enhanced CT. Radiology (1996) 1.25
The role of innate immunity in the induction of autoimmunity. Autoimmun Rev (2008) 1.21
Lupus enteritis: clinical characteristics, risk factor for relapse and association with anti-endothelial cell antibody. Lupus (2007) 1.19
Lupus-associated pancreatitis. Autoimmun Rev (2006) 1.18
Systemic lupus erythematosus one disease or many? Autoimmun Rev (2011) 1.18
Pneumatosis cystoides intestinalis in systemic lupus erythematosus with intestinal vasculitis: treatment with high dose prednisone. Clin Rheumatol (1994) 1.16
Prospective study on the role of C-reactive protein (CRP) in patients with an acute abdomen. Ann R Coll Surg Engl (2007) 1.10
Gastrointestinal manifestations of systemic lupus erythematosus. Curr Opin Rheumatol (2000) 1.09
Systemic lupus erythematosus and chronic intestinal pseudoobstruction. J Rheumatol (1993) 1.08
Intestinal ischemia as the first manifestation of vasculitis. Semin Arthritis Rheum (2004) 1.06
Pathogenesis of malignant ascites: Starling's law of capillary hemodynamics revisited. Ann Oncol (2001) 1.06
Acute abdominal complications of systemic lupus erythematosus. Br J Surg (1978) 1.03
Acute gastrointestinal distress syndrome in patients with systemic lupus erythematosus. Lupus (2007) 1.03
Eosinophilic enteritis with systemic lupus erythematosus. South Med J (2005) 1.03
Evaluation of abdominal pain in systemic lupus erythematosus. Am J Surg (1998) 1.02
Pneumatosis cystoides intestinalis following lupus enteritis and peritonitis. Intern Med (2008) 1.01
Systemic lupus erythematosus and intestinal venulitis. Gastroenterology (1981) 1.01
CT findings at lupus mesenteric vasculitis. Acta Radiol (1997) 0.98
Acute abdomen in systemic lupus erythematosus: the importance of early laparotomy. Am J Med (1997) 0.98
Pulse steroids: how much is enough? Autoimmun Rev (2005) 0.94
Gastrointestinal vasculitis and pneumatosis intestinalis due to systemic lupus erythematosus: successful treatment with pulse intravenous cyclophosphamide. Am J Med (1988) 0.94
Acute reversible lupus vasculitis of the gastrointestinal tract. Radiology (1974) 0.93
THE ASSOCIATION OF CHRONIC "NONSPECIFIC" INFLAMMATORY BOWEL DISEASE WITH LUPUS ERYTHEMATOSUS. Ann Intern Med (1964) 0.92
Rapid onset of massive ascites as the initial presentation of systemic lupus erythematosus. Am J Gastroenterol (2000) 0.91
Subacute abdominal pain requiring hospitalization in a systemic lupus erythematosus patient: a retrospective analysis and review of the literature. Lupus (2001) 0.88
Bowel perforation and interstitial cystitis in childhood systemic lupus erythematosus. J Rheumatol (1991) 0.87
Vasculitis in systemic lupus erythematosus. Lupus (1997) 0.87
Lupus peritonitis mimicking acute surgical abdomen in a patient with systemic lupus erythematosus: report of a case. Surg Today (1996) 0.86
Systemic lupus erythematosus serositis. Australas Radiol (1995) 0.86
[Lupus enteritis: an uncommon manifestation of systemic lupus erythematosus with favourable outcome on corticosteroids]. Rev Med Interne (2010) 0.85
Double-contrast radiographic assessment of lupus-associated enteropathy. Clin Radiol (1998) 0.84
Images in clinical medicine. Lupus-associated intestinal vasculitis. N Engl J Med (2009) 0.84
Abdominal computed tomography in lupus mesenteric arteritis. Comput Med Imaging Graph (1992) 0.83
Reversible thickening of the bowel and urinary bladder wall in systemic lupus erythematosus: a case report. Radiat Med (1996) 0.83
Lupus enteritis detected by capsule endoscopy. Intern Med (2007) 0.83
Systemic lupus erythematosus complicated by intestinal vasculitis and pneumatosis intestinalis. Rev Bras Reumatol (2010) 0.83
Acute abdomen and lupus enteritis: thrombocytopenia and pneumatosis intestinalis as indicators for surgery. Am Surg (2000) 0.82
Case records of the Massachusetts General Hospital. Weekly clinicopathological exercises. Case 25-1978. N Engl J Med (1978) 0.82
Successful treatment of recurrent lupus enteritis with rituximab. Lupus (2009) 0.81
Abdominal pain as the initial and sole clinical presenting feature of systemic lupus erythematosus. Can J Gastroenterol (2003) 0.81
Rituximab treatment of systemic lupus erythematosus in controlled trials and in clinical practice: Two sides of the same coin. Autoimmun Rev (2010) 0.81
Severe gastrointestinal involvement in systemic lupus erythematosus treated with rituximab and cyclophosphamide (B-cell depletion therapy). Lupus (2007) 0.80
Mesenteric vasculitis as the initial presentation in children with systemic lupus erythematosus. J Pediatr Gastroenterol Nutr (2009) 0.79
Simultaneous herpes simplex virus esophagitis and lupus enteritis in a patient with systemic lupus erythematosus. Mod Rheumatol (2009) 0.78
Systemic lupus erythematosus associated with recurrent lupus enteritis and peritonitis. Clin Rheumatol (2004) 0.77
[Recurrent ileitis in disseminated lupus erythematosus. Therapeutic and nutritional problems]. Rev Med Interne (1981) 0.77
Pre-operative radiological diagnosis of acute necrotizing enteritis in systemic lupus erythematodes. J Belge Radiol (1990) 0.77
Education and imaging. Gastrointestinal: intestinal vasculitis associated with systemic lupus erythematosus. J Gastroenterol Hepatol (2008) 0.76
Usefulness of intraoperative esophagogastroduodenoscopy in a patient with lupus enteritis. Fukushima J Med Sci (2008) 0.76
Terminal ileitis in a patient with systemic lupus erythematosus. Isr J Med Sci (1985) 0.76
Functional delineation and differentiation dynamics of human CD4+ T cells expressing the FoxP3 transcription factor. Immunity (2009) 9.01
High-dose melphalan versus melphalan plus dexamethasone for AL amyloidosis. N Engl J Med (2007) 5.84
Antiphospholipid syndrome: clinical and immunologic manifestations and patterns of disease expression in a cohort of 1,000 patients. Arthritis Rheum (2002) 5.12
Regulatory T-cell responses to low-dose interleukin-2 in HCV-induced vasculitis. N Engl J Med (2011) 4.39
Dramatic efficacy of vemurafenib in both multisystemic and refractory Erdheim-Chester disease and Langerhans cell histiocytosis harboring the BRAF V600E mutation. Blood (2012) 3.96
High prevalence of BRAF V600E mutations in Erdheim-Chester disease but not in other non-Langerhans cell histiocytoses. Blood (2012) 3.44
XIAP deficiency in humans causes an X-linked lymphoproliferative syndrome. Nature (2006) 3.30
The systemic capillary leak syndrome: a case series of 28 patients from a European registry. Ann Intern Med (2011) 2.88
Safety and efficacy of rituximab in systemic lupus erythematosus: results from 136 patients from the French AutoImmunity and Rituximab registry. Arthritis Rheum (2010) 2.68
Leiomyosarcoma of the inferior vena cava: experience in 22 cases. Ann Surg (2006) 2.65
CNS involvement and treatment with interferon-α are independent prognostic factors in Erdheim-Chester disease: a multicenter survival analysis of 53 patients. Blood (2011) 2.59
Efficacy and safety of first-line rituximab in severe, acquired thrombotic thrombocytopenic purpura with a suboptimal response to plasma exchange. Experience of the French Thrombotic Microangiopathies Reference Center. Crit Care Med (2012) 2.51
Development and validation of the HScore, a score for the diagnosis of reactive hemophagocytic syndrome. Arthritis Rheumatol (2014) 2.40
The immune paradox of sarcoidosis and regulatory T cells. J Exp Med (2006) 2.35
Cardiovascular involvement, an overlooked feature of Erdheim-Chester disease: report of 6 new cases and a literature review. Medicine (Baltimore) (2004) 2.27
High incidence of Kaposi sarcoma-associated herpesvirus-related non-Hodgkin lymphoma in patients with HIV infection and multicentric Castleman disease. Blood (2002) 2.26
Association of Takayasu's arteritis and Crohn's disease. Results of a study on 44 Takayasu patients and review of the literature. Ann Med Interne (Paris) (2003) 2.25
Long-term efficacy and safety of low-dose interferon alpha2a therapy in severe uveitis associated with Behçet disease. Am J Ophthalmol (2008) 2.24
Herpes simplex virus type 2 as a cause of severe meningitis in immunocompromised adults. Clin Infect Dis (2003) 2.24
Low blood concentration of hydroxychloroquine is a marker for and predictor of disease exacerbations in patients with systemic lupus erythematosus. Arthritis Rheum (2006) 2.22
Joint European League Against Rheumatism and European Renal Association-European Dialysis and Transplant Association (EULAR/ERA-EDTA) recommendations for the management of adult and paediatric lupus nephritis. Ann Rheum Dis (2012) 2.21
Time course of organ dysfunction in thrombotic microangiopathy patients receiving either plasma perfusion or plasma exchange. Crit Care Med (2006) 2.21
Granulomatosis-associated common variable immunodeficiency disorder: a case-control study versus sarcoidosis. Eur Respir J (2012) 2.11
Antiviral therapy for hepatitis C virus--associated mixed cryoglobulinemia vasculitis: a long-term followup study. Arthritis Rheum (2006) 2.09
Erdheim-Chester disease. Curr Opin Rheumatol (2012) 2.08
A combined pulmonary-radiology workshop for visual evaluation of COPD: study design, chest CT findings and concordance with quantitative evaluation. COPD (2012) 2.07
Rituximab efficacy and safety in adult splenectomy candidates with chronic immune thrombocytopenic purpura: results of a prospective multicenter phase 2 study. Blood (2008) 2.07
Low T cell responses to human herpesvirus 8 in patients with AIDS-related and classic Kaposi sarcoma. J Infect Dis (2006) 2.02
Global natural regulatory T cell depletion in active systemic lupus erythematosus. J Immunol (2005) 2.00
Late-onset combined immune deficiency: a subset of common variable immunodeficiency with severe T cell defect. Clin Infect Dis (2009) 2.00
Vasculitides associated with malignancies: analysis of sixty patients. Arthritis Rheum (2007) 1.97
Infections in 252 patients with common variable immunodeficiency. Clin Infect Dis (2008) 1.93
Systemic perturbation of cytokine and chemokine networks in Erdheim-Chester disease: a single-center series of 37 patients. Blood (2011) 1.93
Proposal for a new set of classification criteria for adult-onset still disease. Medicine (Baltimore) (2002) 1.88
Association of the R92Q TNFRSF1A mutation and extracranial deep vein thrombosis in patients with Behçet's disease. Arthritis Rheum (2005) 1.85
Systemic IFN-alpha drives kidney nephritis in B6.Sle123 mice. Eur J Immunol (2008) 1.84
Renal sarcoidosis: clinical, laboratory, and histologic presentation and outcome in 47 patients. Medicine (Baltimore) (2009) 1.81
Reactive hemophagocytic syndrome in adult systemic disease: report of twenty-six cases and literature review. Arthritis Rheum (2003) 1.78
Intensive care in patients with newly diagnosed malignancies and a need for cancer chemotherapy. Crit Care Med (2005) 1.78
Antiphospholipid syndrome nephropathy in systemic lupus erythematosus. J Am Soc Nephrol (2002) 1.78
Mycophenolic acid area under the curve correlates with disease activity in lupus patients treated with mycophenolate mofetil. Arthritis Rheum (2010) 1.75
Romiplostim safety and efficacy for immune thrombocytopenia in clinical practice: 2-year results of 72 adults in a romiplostim compassionate-use program. Blood (2011) 1.71
Bone involvement in Erdheim-Chester disease: imaging findings including periostitis and partial epiphyseal involvement. Radiology (2005) 1.69
Cardiac sarcoidosis: a retrospective study of 41 cases. Medicine (Baltimore) (2004) 1.68
Baseline results of the Depiscan study: a French randomized pilot trial of lung cancer screening comparing low dose CT scan (LDCT) and chest X-ray (CXR). Lung Cancer (2007) 1.68
Acute renal infarction: a case series. Clin J Am Soc Nephrol (2012) 1.68
Management of adult patients with Langerhans cell histiocytosis: recommendations from an expert panel on behalf of Euro-Histio-Net. Orphanet J Rare Dis (2013) 1.67
The enlarging clinical, genetic, and population spectrum of tumor necrosis factor receptor-associated periodic syndrome. Arthritis Rheum (2002) 1.67
Long-term outcomes of pandemic 2009 influenza A(H1N1)-associated severe ARDS. Chest (2012) 1.66
Rituximab plus Peg-interferon-alpha/ribavirin compared with Peg-interferon-alpha/ribavirin in hepatitis C-related mixed cryoglobulinemia. Blood (2010) 1.64
Systemic non-Hodgkin lymphoma in HIV-infected patients with effective suppression of HIV replication: persistent occurrence but improved survival. J Acquir Immune Defic Syndr (2002) 1.63
Fluorescein and indocyanine green angiographies in Susac syndrome. Retina (2007) 1.62
Idiopathic interstitial pneumonias: CT features. Radiology (2005) 1.61
Plasmatic level of leukocyte-derived microparticles is associated with unstable plaque in asymptomatic patients with high-grade carotid stenosis. J Am Coll Cardiol (2013) 1.61
Phenotype and function of natural killer cells in systemic lupus erythematosus: excess interferon-γ production in patients with active disease. Arthritis Rheum (2011) 1.59
Multiparameter grouping delineates heterogeneous populations of human IL-17 and/or IL-22 T-cell producers that share antigen specificities with other T-cell subsets. Eur J Immunol (2011) 1.59
Safety of hydroxychloroquine in pregnant patients with connective tissue diseases: a study of one hundred thirty-three cases compared with a control group. Arthritis Rheum (2003) 1.59
The spectrum of Evans syndrome in adults: new insight into the disease based on the analysis of 68 cases. Blood (2009) 1.59
Human FoxP3+ regulatory T cells in systemic autoimmune diseases. Autoimmun Rev (2011) 1.59
Adrenal involvement in the antiphospholipid syndrome: clinical and immunologic characteristics of 86 patients. Medicine (Baltimore) (2003) 1.58
Variability in the efficacy of interferon-alpha in Erdheim-Chester disease by patient and site of involvement: results in eight patients. Arthritis Rheum (2006) 1.58
Clinical similarities and differences of patients with X-linked lymphoproliferative syndrome type 1 (XLP-1/SAP deficiency) versus type 2 (XLP-2/XIAP deficiency). Blood (2010) 1.55
Small-vessel vasculitis surrounding an uninflamed temporal artery: a new diagnostic criterion for polymyalgia rheumatica? Arthritis Rheum (2008) 1.55
Rituximab may form a complex with IgMkappa mixed cryoglobulin and induce severe systemic reactions in patients with hepatitis C virus-induced vasculitis. Arthritis Rheum (2009) 1.55
Deficiency of type I IFN receptor in lupus-prone New Zealand mixed 2328 mice decreases dendritic cell numbers and activation and protects from disease. J Immunol (2009) 1.55
IgG4-related systemic disease: features and treatment response in a French cohort: results of a multicenter registry. Medicine (Baltimore) (2012) 1.54
Cerebral, facial, and orbital involvement in Erdheim-Chester disease: CT and MR imaging findings. Radiology (2010) 1.53
Magnetic resonance imaging criteria for distinguishing between inclusion body myositis and polymyositis. J Rheumatol (2002) 1.50
Pathogenesis of Takayasu's arteritis: a 2011 update. Autoimmun Rev (2011) 1.49
Prospective study of rituximab in chemotherapy-dependent human immunodeficiency virus associated multicentric Castleman's disease: ANRS 117 CastlemaB Trial. J Clin Oncol (2007) 1.49
Understanding organ dysfunction in hemophagocytic lymphohistiocytosis. Intensive Care Med (2008) 1.48
Neurological manifestations and neuroradiological presentation of Erdheim-Chester disease: report of 6 cases and systematic review of the literature. J Neurol (2006) 1.47